Onconetix: Board of Directors Approved 1-for-10 Reverse Stk Split of Outstanding Common Stk, Expected to Become Effective on Nov 6 >ONCO

What happened

Onconetix said its board of directors approved a 1-for-10 reverse stock split of its outstanding common stock. The company expects the reverse split to become effective on November 6.

Confirmed

Global impact / market context

A 1-for-10 reverse split combines every ten existing shares into one, reducing the number of shares while raising the price per share. The move does not change the company's underlying value or operations, but it can help Onconetix meet minimum share price rules.

Analyst inference

Reverse splits are often used by companies whose shares trade at low prices, since exchanges can require a minimum price to stay listed. The change affects how shares are counted, priced, and displayed, which matters to existing holders and anyone tracking Onconetix.

Analyst inference

What to watch

1. The reverse stock split is expected to take effect on November 6, after the board approved the 1-for-10 ratio. Confirmed
2. Watch whether Onconetix shares trade at roughly ten times the pre-split price, with the total number of shares reduced accordingly. Analyst inference
3. Investors should check company filings for final split details, including how fractional shares are handled and any change to the stock's ticker symbol. Proposed

Evidence

• Original source link unavailable